Carter Ledyard Client Trinity Biotech Agrees to Sell Fitzgerald Industries to Biosynth
Carter Ledyard’s client, Trinity Biotech plc (Nasdaq: TRIB), announced its agreement to sell its life sciences supply business unit, Fitzgerald Industries, for cash proceeds of approximately $30 million. The expected…